A. Fournet et al., ACTIVITY OF COMPOUNDS ISOLATED FROM CHILEAN LICHENS AGAINST EXPERIMENTAL CUTANEOUS LEISHMANIASIS, Comparative biochemistry and physiology. Part C, Pharmacology toxicology & endocrinology, 116(1), 1997, pp. 51-54
Three secondary metabolites isolated from Chilean lichens, (+) usnic a
cid, pannarine and 1'-chloropannarine, were tested against promastigot
es forms of three strains of Leishmania ssp. Pannarine and 1'-chloropa
nnarine exhibited in vitro activity at 50 mu g/ml and (+) usnic acid a
t 25 mu g/ml. BALB/c mice infected with Leishmania amazonensis were tr
eated 4 weeks post-infection with (+) usnic acid by subcutaneous or or
al routes for 15 days at 25 mg/kg or by five intralesional injections
at interval of 4 days at 25 mg/kg of body weight. The reference drug,
N-methylglucamine antimonate (Glucantime), was administered by subcuta
neous injections (regimens of 28 mg of pentavalent antimony) for 15 da
ys. The subcutaneous and oral treatments with (+) usnic did not produc
e any effect, but by intralesional administration we observed a signif
icant effect that reduced by 43.34% the weight lesions and by 72.28% t
he parasites loads in infected footpads. Copyright (C) 1997 Elsevier S
cience Inc.